We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.AuthorsComi, G.; O'Connor, P.; Montalban, X.; Antel, J.; Radue, E.-W.; Karlsson, G.; Pohlmann, H.; Aradhye, S.; Kappos, L.PublicationMultiple Sclerosis (13524585), 2010, Vol 16, Issue 2, p197ISSN1352-4585Publication typearticleDOI10.1177/1352458509357065